THE UNIVERSITY OF TEXAS MEDICAL BR. — History
CCN 450018 | 3-year financial timeline | COVID resilience: 44/100
🛡️ Public data only — no PHI permitted on this instance.
$1.2B
Latest Revenue (FY2022)
+7.4%
Revenue CAGR (3yr)
-29.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $1.0B | $1.1B | $1.2B | +11.0% | +7.4% |
| Operating Expenses | $1.2B | $1.4B | $1.5B | +11.8% | +11.7% |
| Operating Margin | -20.0% | -29.0% | -29.9% | -3.0% | +0.0% |
| Net Income | $-207M | $-312M | $-357M | -14.4% | +0.0% |
| Licensed Beds | 804 | 810 | 819 | +1.1% | +0.9% |
| Total Patient Days | 184,350 | 189,329 | 191,716 | +1.3% | +2.0% |
| Medicare Day % | 17% | 15% | 13% | -14.0% | -12.2% |
| Medicaid Day % | 4% | 4% | 3% | -8.2% | -5.2% |
COVID Impact & Recovery
Resilience Score: 44/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +15.3% ($1.0B → $1.2B)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+7.4%
This Hospital
+7.6%
State Avg
Latest Margin
-29.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $1.3B | -34.9% |
| FY2024 (proj) | $1.4B | -39.8% |
| FY2025 (proj) | $1.4B | -44.8% |